Skip to main content
OpenTrials
Completed

NCT Number: NCT02689349

Esteem New Subject Enrollment Post Approval Study

The New Enrollment Post-Approval Study is designed to evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from moderate to severe hearing loss.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

North Alabama ENT Associates, Madison, Alabama, United States

Loading trial locations.

About this study

Purpose:

To evaluate the long-term safety and efficacy of the Esteem Totally Implantable Hearing System (hereafter called Esteem) in subjects suffering from moderate to severe hearing loss.

Questions:

The following questions are to be answered:

  • Is Esteem effective through 1 year follow-up?
  • Is Esteem safe through 1 year follow-up?
  • Is the incidence of facial paresis/paralysis at 1 month follow-up no greater than 7%?

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is ≥ 18 years old
  • Subject understands the nature of the procedure and has signed the Subject Informed Consent Form prior to the procedure
  • Subject is willing and able to comply with specified follow-up evaluations and understands the audiological test procedures and use of the Esteem® System.
  • Subject has moderate to severe sensorineural hearing loss in the ear to be implanted defined by pure tone average air-conduction threshold level.
  • Subject has an unaided maximum word recognition score of greater than or equal to 40% with recorded delivery using a phonetically balanced word list at SRT + 40 decibels (dB) or at maximum tolerable presentation level.
  • Subject is a current user of a properly functioning and appropriately fit hearing aid for at least one (1) month in the ear to be implanted.
  • Subject has normally functioning eustachian tube
  • Subject has normal tympanic membrane
  • Subject has a normal middle ear anatomy
  • Subject has adequate space for Esteem® System implant determined via fine cut temporal bone CT scan
  • Subject is a native speaker of the English language.

Exclusion criteria

  • Subject has a history of post-adolescent chronic middle ear infections, inner ear disorders or recurring vertigo requiring treatment, disorders such as mastoiditis, Hydrops or Meniere's syndrome or disease
  • Subject has a history of otitis externa or eczema for the outer ear canal and the investigator believes this will affect the Esteem® System implantation
  • Subject has cholesteatoma or destructive middle ear disease
  • Subject has life expectancy of < two (2) years due to other medical conditions
  • Subject has retrocochlear or central auditory disorders
  • Subject is known to be suffering from any psychological, developmental, physical, or emotional disorder that the investigator feels would interfere with the surgery or follow-up testing
  • Subject has a known history of fluctuating air conduction and/or bone conduction hearing loss over a one-year period of 15 dB in either direction at 2 or more frequencies (from 500 - 4000 Hz)
  • Subject has sudden hearing loss due to unknown cause
  • Subject has a history of disabling tinnitus, defined as tinnitus which required treatment.
  • Subject is unable to adequately perform audiological testing
  • Subject has a medical condition or undergoing a treatment that may affect healing and the investigator does not believe the subject is a good candidate for the trial.
  • Subject has diabetes that is not well controlled with medication or diet and the investigator does not believe in his best medical judgment that the subject would be a good candidate for the trial
  • Subject is pregnant at the time of device implant
  • Subject has a history of keloid formation
  • Subject has known hypersensitivity to silicone rubber, polyurethane, stainless steel, titanium and/or gold

Treatment and study plan

Implantation of Esteem

Device

Subjects meeting indications are implanted with the Esteem Totally Implantable Hearing System

Primary outcomes

  1. Change in Speech Reception Threshold (SRT)

    Time frame: Change in SRT from Baseline Aided to 10-month post-activation with Esteem

    Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition. The SRT is related to hearing sensitivity; lower numbers indicate better outcomes. Here, the difference in dB is reported; positive scores indicate improvement (lower SRT) with the Esteem relative to the pre-implant hearing aid. There are no specific minimum or maximum scores for this measure.

  2. Change in Word Recognition Score (WRS)

    Time frame: Change in WRS from Baseline Aided to 10-month post-activation with Esteem

    Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition. For WRS, a higher score indicates a better outcome. Here, the difference in % correct is reported; positive scores indicate better performance with the Esteem relative to the pre-implant hearing aid. Scores on this test range from 0 to 100%.

  3. Incidence of SADEs, Device Failures, & Replacements

    Time frame: Incidence at 10-month post-activation

    The analysis of the incidence of Serious Adverse Device Effects (SADEs) and device failures and replacements

  4. Incidence of Facial Pareses/Paralysis

    Time frame: Incidence at one month post-op

    The analysis of the incidence of facial pareses/paralysis at one month follow-up

  5. Change in Bone Conduction Threshold (BCT) at 500 Hz

    Time frame: Change in BCT from Baseline to 10-month post-activation

    Comparison of bone conduction (BC) threshold at 500 Hz post activation compared to the pre-implant BC threshold. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.

  6. Change in Bone Conduction Threshold (BCT) at 1000 Hz

    Time frame: Change in BCT from Baseline to 10-month post-activation

    Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.

  7. Change in Bone Conduction Threshold (BCT) at 2000 Hz

    Time frame: Change in BCT from Baseline to 10-month post-activation

    Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.

  8. Change in Bone Conduction Threshold (BCT) at 4000 Hz

    Time frame: Change in BCT from Baseline to 10-month post-activation

    Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.

Secondary outcomes

  1. Change in Subjective Quality of Life as Measured With the Abbreviated Profile of Hearing Aid Benefit, or APHAB (Global Score)

    Time frame: Change from Baseline Aided to 10-month post-activation with Esteem

    Quality of Life measured with the APHAB comparison between the pre-implant aided condition and 10-month post-activation. In general, a lower score indicates better performance. The range of scores for each subscale (including the Global score, reported here) is 1 to 99. Here, mean difference in benefit score with the Esteem implant vs. pre-implant aided condition is reported. A positive difference score indicates more benefit with the Esteem.

  2. Esteem Questionnaire Results

    Time frame: 10-month post-activation with Esteem

    To gather subject feedback and comments on the use of the Esteem System through subject ratings on questionnaire items specifically focusing on factors such as the clarity of sound, the user's ability to understand speech in background noise, naturalness of sound, benefits of the system, etc. -- relative to the pre-implant aided condition. Subjects rated each item as "Is much worse", "Somewhat worse", "Is about the same", "Is somewhat better", or "Is much better" with the Esteem. Reported here are the cumulative number of respondents indicating "Same", "Somewhat better", or "Much better" for the given question.

Sponsors and collaborators

Lead sponsor

Envoy Medical Corporation

Industry

Registry information

Official study title

Esteem Totally Implantable Hearing System New Subject Enrollment Post Approval Study

Important dates

Study start
2010
Primary completion
2021
Study completion
2021
First posted
Feb 23, 2016
Registry last updated
Jun 27, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.